whatshot

PFE   $24.6258  0.35% Market Open

Pfizer, Inc.
show_chart Advanced Chart of PFE
  • Volume
  • EMA (20)
  • EMA (50)
  • EMA (100)
  • MACD
  • RSI (14)
  • Stochastic
Last Events:

2023-12-13 The hottest instrument.

2023-10-16 The hottest instrument.

2023-10-15 The hottest instrument.

2023-10-13 The hottest instrument.

2023-08-26 The hottest instrument.

2023-08-09 Signal in Stochastic changed from bearish weakening to bullish reversal. The stochastic indicator is in the lower part of the neutral territory and left the oversold territory. These factors indicate that perhaps the downside trend is coming to an end price will probably head north Last signal: exit from the oversold zone.

2023-08-09 Signal in MACD changed from bearish recovery to bearish weakening. Oscillator MACD is in the negative territory it's lower than the signal line and grows. These factors mean that the falling trend persists, but the growth rate is declining. Last signal: main and signal line crossing.

2023-08-06 Signal in Stochastic changed from bearish recovery to bearish weakening. The stochastic indicator is in the oversold territory and it heading north. These factors indicate that perhaps the downside trend is coming to an end. Last signal: main and signal line crossing.

Current temperature: 17.17
ST: 0, Cor:

50-50 Year Forecast
Low with % probability:
Target: 25.50
High with % probability:
Analyst Recommendations:
Number of estimates 19
Target Price Mean 30.86
Mean unverified/preliminary 30.86 / 30.86
Target Price Low / High 25.00 / 41.43
Median / STD DEV 30.00 / 3.88
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Sell Sell
rsi ActivelyBuy Sell None
macd None None None
stoch None None None
ma20 Sell Sell None
ma50 None None None
ma100 Sell Sell Sell
Candlestick PatternApril 1, 2025 After Top Gap Down - pattern is a made up of five candlesticks. Pattern appears on a uptrend. The pattern begins with a white candlestick. The next two days are also white days. The third day gaps up and opens above the close of the second day. The fifth day is a strong black with a gap below the previous day’s close. Considered to be a bearish reversal pattern.
ISIN US7170811035
ceo Dr. Albert Bourla D.V.M., Ph.D.
Website https://www.pfizer.com
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.